PRESS RELEASE published on 01/20/2026 at 07:45, 7 months 24 days ago Le projet de plan de continuation de REALITES obtient un très fort soutien de ses créanciers et actionnaires en vue de l’audience du 4 février 2026 au Tribunal de Commerce de Nantes Le projet de plan de continuation de REALITES obtient un très fort soutien de ses créanciers et actionnaires en vue de l’audience du 4 février 2026 au Tribunal de Commerce de Nantes AUDIENCE Plan De Continuation REALITES Soutien Tribunal De Commerce De Nantes
PRESS RELEASE published on 01/20/2026 at 07:35, 7 months 24 days ago Andera Partners’ Portfolio Company Exciva Secures €51 Million Series B to Advance Clinical Program for Alzheimer’s-Related Agitation Andera Partners' portfolio company Exciva secures €51 million Series B funding for Alzheimer's-related agitation clinical program, led by Gimv and EQT Life Sciences Series B Funding Alzheimer's Disease Clinical Program Andera Partners Exciva
PRESS RELEASE published on 01/20/2026 at 07:30, 7 months 24 days ago Circus Defence Delivers AI Robots to the German Armed Forces Circus Defence awarded contract to deliver AI robots to German Armed Forces for autonomous supply, ensuring continuous support to soldiers. Integration starts at military barracks in Germany German Armed Forces Circus Defence Autonomous Supply AI Robots Military Barracks
PRESS RELEASE published on 01/20/2026 at 07:30, 7 months 24 days ago Vienna Airport sets new passenger records in 2025 with 43.4 million (Flughafen Wien Group) and 32.6 million (Vienna) and record cargo volume Vienna Airport sets new passenger records in 2025 with 43.4 million (Flughafen Wien Group) and 32.6 million (Vienna) with record cargo volume. Financial outlook for 2026 includes stable net profit despite challenges Financial Outlook 2025 Cargo Volume Vienna Airport Record Passenger
REGULATED PRESS RELEASE published on 01/20/2026 at 07:30, 7 months 24 days ago Gimv leidt een Series B investeringsronde van EUR 51 miljoen in Exciva voor verdere ontwikkeling van een innovatieve Alzheimerbehandeling Gimv leidt een Series B investeringsronde van EUR 51 miljoen in Exciva voor verdere ontwikkeling van een innovatieve Alzheimerbehandeling Gimv Series B EUR 51 Miljoen Exciva Alzheimerbehandeling
REGULATED PRESS RELEASE published on 01/20/2026 at 07:30, 7 months 24 days ago Gimv leads € 51 million Series B investment round in Exciva to advance innovative Alzheimer’s therapy Gimv mène une levée de fonds de 51 millions d'euros pour Exciva afin de faire avancer une thérapie innovante contre la maladie d'Alzheimer Investissement Gimv Alzheimer Thérapie Exciva
REGULATED PRESS RELEASE published on 01/20/2026 at 07:30, 7 months 24 days ago Gimv leads € 51 million Series B investment round in Exciva to advance innovative Alzheimer’s therapy Exciva secures €51m funding led by Gimv and EQT for Alzheimer's therapy. Deraphan targets agitation in Phase II trial, promising improved care for patients Funding Phase II Trial Exciva Alzheimer's Therapy Deraphan
PRESS RELEASE published on 01/20/2026 at 07:30, 7 months 24 days ago Nicox Announces Conference Attendance in H1 2026 and Upcoming Scientific Data Presentations Nicox to attend key ophthalmology conferences and present scientific data at AGS 2026 Annual Meeting. Management team available for meetings. Developing innovative eye health solutions Conference Scientific Data Ophthalmology Nicox Eye Health
PRESS RELEASE published on 01/20/2026 at 07:30, 7 months 24 days ago Nicox annonce sa participation à des congrès au premier semestre 2026 et la présentation prochaine de données scientifiques Nicox annonce sa participation à des congrès au premier semestre 2026 et la présentation prochaine de données scientifiques. L'entreprise spécialisée en ophtalmologie participera à des congrès majeurs et présentera des études clés Ophtalmologie Congrès Nicox NCX 470 Données Scientifiques
PRESS RELEASE published on 01/20/2026 at 07:30, 7 months 24 days ago Bourse Direct : Chiffre d’affaires consolidé 2025 : 76,3 millions d’euros Activité clients soutenue dans un environnement de marché volatil Portefeuille de clients en forte progression avec plus de 400 000 comptes Bourse Direct affiche un chiffre d'affaires consolidé en hausse à 76,3 millions d'euros pour 2025, avec une activité clients dynamique dans un marché volatil. Le courtier enregistre une croissance soutenue, valorise ses offres et reçoit plusieurs récompenses Chiffre D'affaires Croissance Récompenses Bourse Direct Marché Volatil
Published on 09/12/2026 at 02:35, 1 day 20 hours ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 2 days ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 21:25, 2 days 1 hour ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 2 days 6 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/13/2026 at 16:45, 6 hours 23 minutes ago Journées européennes du patrimoine : un succès populaire pour l'ouverture exceptionnelle du Siège de la Vaudoise
Published on 09/12/2026 at 17:50, 1 day 5 hours ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 1 day 15 hours ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 2 days ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 2 days ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 07:00, 2 days 16 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 days 16 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 3 days 3 hours ago Availability of the 2026 Interim Financial Report